Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Probiotics and Systemic Inflammation in Patients With Metabolic Syndrome and High Cardiovascular Risk

NCT04232852 is registered in ClinicalTrials.gov with Attikon Hospital as lead sponsor.

NCT NCT04232852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04232852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Probiotics and Systemic Inflammation in Patients With Metabolic Syndrome and High Cardiovascular Risk
Lead sponsor
Attikon Hospital
Phase
Not applicable
Overall status
Withdrawn
Start date
June 12, 2019
Completion date
January 26, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular risk factor, metabolic syndrome